Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Healthcare Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing

INDUSTRY
Healthcare

RELEASE DATE
10-Sep-2024
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
DB03-01-00-00-00
SKU
HC_2024_1004
Yes
SHARE

$4,950.00

Special Price $4,207.50 save 15 %

In stock
SKU
HC_2024_1004

Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing
Published on: 10-Sep-2024 | SKU: HC_2024_1004

Need more details?

$4,950.00

$4,207.50 save 15 %

DownloadLink
Request Sample
Add to Compare
Need more details?
Description

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized medicine sector. Advancements in technology are also influenced by the pharma 4.0 trend, which entails higher usage of artificial intelligence (AI), the Internet of Things (IoT), and big data analytics. These developments help improve efficiency and productivity, identify errors in manufacturing at an early stage, and maintain audit trails through digitization. They have reduced human intervention, brought flexibility, and made cleanups and changeovers easier. Some of these technologies are already seeing widespread use, while others, such as robotics, are expected to witness a gradual increase in adoption. The effects of modular and automated technologies in manufacturing will be revolutionary in terms of production speeds, error reduction, precision, and cost savings.

The study considers each step in the manufacturing process to analyze the unmet needs and developments in this space. It focuses on widely adopted as well as emerging solutions, listing the key companies offering these advanced technologies. It also provides an overview of the funding and investment landscape and looks at the key partnerships influencing the market. The study analyzes the factors driving and restraining the growth of this industry and identifies the opportunities emerging from the changes in this space for market players and stakeholders to leverage. The base year is 2023, and the forecast period is from 2024 to 2027.

Infographic
Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on Modular and Automated Platforms for Pharmaceutical Manufacturing

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Scope of Analysis

Segmentation

Growth Drivers

Growth Restraints

Steps in the Large-scale Pharma Manufacturing of Small-molecule Drugs

Challenges in Small-molecule Drug Production

Qualities Needed in Blending Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Modular Blending Technologies

Snapshot of Companies with Modular Blending Technologies (continued)

Qualities Needed in Granulation Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Modular Granulation Technologies

Qualities Needed in Tablet Compression/Capsule Filling Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Modular Tablet Compression/Capsule Filling Technologies

Qualities Needed in Tablet Coating Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Tablet Coating Technologies

Qualities Needed in Packing Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Packing Technologies

Modular and Automated Manufacturing Techniques Driven by Pharma 4.0

Modular Manufacturing Technology Use Cases

Modular and Automated Manufacturing Technologies for Sustainable and Personalized Medicines

Present and Future of Modular Technology Adoption in Small-molecule Therapeutics Manufacturing

Industrial Trends due to Modular and Automated Pharmaceutical Manufacturing

Partnerships Promoting Innovative Manufacturing Processes

Fundings and Grants from Private and Public Sources for Manufacturing Technologies

Growth Opportunity 1: Personalized Medicines

Growth Opportunity 1: Personalized Medicines (continued)

Growth Opportunity 2: Sustainability

Growth Opportunity 2: Sustainability

Growth Opportunity 3: Robotics

Growth Opportunity 3: Robotics

Benefits and Impacts of Growth Opportunities

Next Steps

Legal Disclaimer

Request Sample

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Pharmaceuticals and Biotech research

21 Jan 2025   |   Global   |   Technology Research

Technologies Enabling Resilient Pharmaceutical Supply Chains

This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model. The study answers the following questions: What are some new challenges big pharma's supp...

16 Jan 2025   |   Global   |   Technology Research

Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029

Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an an...

28 Oct 2024   |   Global   |   Frost Radar

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024

With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive...

10 Sep 2024   |   Global   |   Market Research

Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market str...

09 Sep 2024   |   Global   |   Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-b...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts
Related Research
  1. Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
    Release Date: 23-Jan-26
  2. Growth Opportunities, Global Life Sciences LIMS Market, Forecast to 2031
    Release Date: 22-Jun-26
  3. Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
    Release Date: 05-May-26
  4. Microrobotics in Precision Medicine: Advancements and Applications for Minimally Invasive Surgeries
    Release Date: 05-Feb-26
  5. Top 10 Technologies for Sustainable Manufacturing in Flexible Electronics
    Release Date: 27-Jan-26

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized medicine sector. Advancements in technology are also influenced by the pharma 4.0 trend, which entails higher usage of artificial intelligence (AI), the Internet of Things (IoT), and big data analytics. These developments help improve efficiency and productivity, identify errors in manufacturing at an early stage, and maintain audit trails through digitization. They have reduced human intervention, brought flexibility, and made cleanups and changeovers easier. Some of these technologies are already seeing widespread use, while others, such as robotics, are expected to witness a gradual increase in adoption. The effects of modular and automated technologies in manufacturing will be revolutionary in terms of production speeds, error reduction, precision, and cost savings. The study considers each step in the manufacturing process to analyze the unmet needs and developments in this space. It focuses on widely adopted as well as emerging solutions, listing the key companies offering these advanced technologies. It also provides an overview of the funding and investment landscape and looks at the key partnerships influencing the market. The study analyzes the factors driving and restraining the growth of this industry and identifies the opportunities emerging from the changes in this space for market players and stakeholders to leverage. The base year is 2023, and the forecast period is from 2024 to 2027.
More Information
Deliverable Type Technology Research
Author Lonita lawrence
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Modular Pharmaceutical Platforms
Keyword 2 Automated Pharma Manufacturing
Keyword 3 Pharmaceutical Technology Innovations
Podcast No
WIP Number DB03-01-00-00-00